Minnesota Oncology is proud to announce that its Cancer Care Pharmacy has been awarded Specialty Pharmacy Accreditation with Distinction in Oncology by Accreditation Commission for Health Care (ACHC). By earning this accreditation, Minnesota Oncology joins an elite, limited group of specialty pharmacies who have been recognized by ACHC for providing cancer patients with exceptional and quality care.
The ACHC Specialty Pharmacy Accreditation with Distinction in Oncology recognizes specialty pharmacies who have demonstrated an outstanding commitment to ensuring cancer patients receive oral cancer drugs and ancillary oral therapies in a safe, reliable, accessible, and affordable environment that is integrated with their overall plan of care. Achieving ACHC Specialty Pharmacy Accreditation with Distinction in Oncology validates Minnesota Oncology’s achievement in meeting and exceeding the highest standards of quality in the delivery of compassionate, personalized cancer care for patients.
“Achieving this accreditation demonstrates Minnesota Oncology’s commitment to compliance with industry standards and best practices, containing costs, and practicing performance improvement in pharmaceutical care,” said Paul Forsberg, PharmD, MHA, BCOP, Director of Pharmacy and Admixture Services at Minnesota Oncology.
In order to achieve ACHC accreditation, the Minnesota Oncology Cancer Care Pharmacy underwent a comprehensive review process that examines organizational structure, policies and procedures, and compliance with state and federal laws. These reviews are conducted every three years by ACHC Surveyors who possess industry-specific experience.
“Our ability to meet and exceed ACHC standards, as well as receiving our certification of distinction in oncology, provides proof that our staff is dedicated to serving oncology/hematology patients requiring highly specialized therapies,” said Brian Meger, PharmD, Pharmacy Services Manager at Minnesota Oncology.
“Our onsite oncology specialty pharmacy is an important part of the comprehensive care we provide for our patients,” said John Schwerkoske, MD, Minnesota Oncology President. “We are so pleased that ACHC recognizes and endorses our commitment to quality in the services we provide to our patients.”
ACHC is a nonprofit organization that has stood as a symbol of quality and excellence since 1986. Accreditation by ACHC reflects an organization’s dedication and commitment to meeting quality standards that facilitate a higher level of performance and patient care. For more information about ACHC visit http://www.achc.org
Share
Categories
Tags
Recent Posts
Being familiar with cancer staging and terminology will help you understand where you are starting and what questions to ask.
Your healthcare provider may recommend additional screening to monitor your small lung nodule and watch for growth over time.
Lung cancer is the second most common type of cancer and the leading cause of cancer death in the U.S. Studies show that lung cancer screening reduces the risk of dying from the disease.